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Purpose: The clinical significance of isolated calf vein thrombosis (CVT), particularly with 
respect o development of the postthrombotic syndrome, remains controversial. The 
purpose of this study was to define the early natural history of CVT in relation to 
persistent lower extremity symptoms, propagation , recanalization, and the development 
of valvular incompetence. 
Methods: Over a 116-month period, 499 patients with acute deep venous thrombosis 
(DVT) were referred to our research laboratory, of whom 58 (12%) had thrombosis 
confined to the calf veins of at least one extremity. The lower extremities of 268 patients 
(29 with isolated CVT) were followed-up clinically and with duplex ultrasonography at 
intervals of 1 day, 7 days, 1 month, every 3 months for the first year, and yearly 
thereafter. 
Results: Seventy percent of extremities with CVT were symptomatic at presentation. 
Although the prevalence of clinical signs and symptoms decreased to 29% by 1 month, 
23% of patients had persistent pain, edema, or both at 12 months. In contrast~ 9% of 
uninvolved extremities contralateral toa CVT and 54% of extremities with proximal DVT 
remained symptomatic at1 year (p = 0.004). Recanalization proceeded rapidly such that 
the mean thrombus load was reduced by 50% at 1 month and to zero at 1 year. The 
prevalence of valvular incompetence progressively increased such that reflux was present 
in 24% of extremities at 1 year. Although its investigation was not a primary goal of this 
study, pulmonary embolism was diagnosed at presentation and during follow-up in 11% 
and 3% of patients, respectively. 
Conclusions." The natural history of CVT is complicated by persistent symptoms and the 
development of valvular incompetence in approximately one-quarter of patients. This 
potential for persistent lower extremity s mptoms should be considered in evaluating the 
clinical relevance of isolated calf vein DVT. (J Vasc Surg 1997;26:749-56.) 
In defining the natural history of acute deep ve- 
nous thrombosis (DVT), a distinction is often made 
between involvement of  the proximal and distal (calf) 
veins. This differentiation arises from perceived if- 
ferences in the incidence of the two primary compli- 
cations of DVT, pulmonary embolism (PE) and the 
postthrombotic syndrome. The risk of these compli- 
cations after a proximal thrombosis has been well 
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defined over the past several years. 1,2Correspond- 
ingly, multiple clinical trials have assisted in defining 
the optimal management of proximal DVT, particu- 
larly with respect o minimizing thrombus propaga- 
tion and PE. 3-~ 
Isolated calf vein thrombosis (CVT) is thought o 
be associated with a substantially ower risk of PE,  6'7 
although the significance of this risk remains contro- 
versial, s-ll The relationship between CVT and the 
postthrombotic syndrome is even more poorly de- 
fined and is often not considered in discussing the 
clinical significance of CVT. Although such thrombi 
may undergo rapid spontaneous lysis, :t2 their distal 
anatomic location poses a theoretical risk for the 
ultimate development ofpostthrombotic syndrome? 
Given these limitations, it is not surprising that the 
optimal management of isolated calf vein thrombo- 
sis, including the need for anticoagulation, remains 
controversial. 
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The purpose of this study was to define the early 
natural history of isolated CVT in a series of patients 
who were followed-up with serial clinical and duplex 
ultrasound evaluations. 
METHODS 
All patients who had an acute lower extremity 
DVT documented by duplex ultrasonography at
the University of Washington Medical Center have 
been asked to participate in a longitudinal study of 
the natural history of acute DVT. Patients who 
consent o participate are requested to return for 
clinical and duplex ultrasound examinations of the 
lower extremities at intervals of 1 and 7 days; 1, 3, 
6, 9, and 12 months; and yearly thereafter. At each 
visit, patients are questioned about lower extrem- 
ity symptoms; their limbs are evaluated for edema, 
hyperpigmentation, a d ulceration; and a detailed 
ultrasound examination of all deep venous seg- 
ments from the inferior vena cava to the tibial veins 
is performed. Ultrasound evaluation includes an 
assessment of the paired posterior tibia] and pero- 
neal veins as well as the sural veins. Isolated throm- 
bosis of the anterior tibial veins is uncommon, 13
and these segments were not routinely imaged. 
The results of all studies are communicated to the 
patients' primary physician, who makes all treat- 
ment decisions. Only patients who have pulmo- 
nary symptoms underwent further diagnostic stud- 
ies for PE, and this was at the discretion of their 
primary physician. The study protocol has been 
approved by the Human Subjects Committee at 
the University of  Washington. 
Duplex examinations were performed in 15 de- 
grees reverse Trendelenburg (feet down) position 
using an Ultramark 8 or 9 scanner (Advanced Tech- 
nology Laboratories, Bothell, Wash.). A 5 MHz 
pulsed Doppler was used for evaluation of the prox- 
imal venous egments, and a 10 MHz transducer was 
used for the tibia] veins. Beginning in 1990, a 5 MHz 
linear array color transducer was used to facilitate 
visualization of the tibia] veins. Examinations in- 
cluded an evaluation of flow characteristics and com- 
pressibility as well as an assessment of reflux in re- 
sponse to Va]sa]va's and compression maneuvers. All 
venous segments were classified as completely oc- 
cluded, partially occluded, or patent. An incompress- 
ible segment without flow by either pulsed or color 
flow Doppler was considered completely occluded, 
whereas an incompressible segment with flow 
present was considered partially occluded. As sponta- 
neous flow may be normally absent in the calf veins, a 
completely compressible vein that demonstrated 
flow with or without distal augmentation was de- 
fined as patent. 
Thrombi solated to the posterior tibia], peronea], 
or sura] veins were defined as CVTs; those involving 
venous egments from the vena cava to the popliteal 
vein were considered proximal thromboses. A tibial 
thrombosis core was calculated for each extremity 
with CVT on the basis of a modification of the 
SVS/ISCVS reporting standards in venous disease.14 
For each calf vein, including the sura] veins, the 
thrombus load was scored as 2 if completely oc- 
cluded, 1 if partially occluded, and 0 if patent. An 
extremity without hrombosis of any calf vein would 
therefore be given a score of 0, whereas a limb with 
complete occlusion of both pairs of posterior tibia] 
and peroneal veins would receive a score of 8. The 
rate of recanalization was then quantified by the 
decrease in tibia] thrombosis score over time, 
whereas propagation was defined as extension of 
thrombus to more proximal segments in the same 
limb. 
Because the number of patients with isolated 
CVT was small and because not all patients attended 
each scheduled visit, follow-up intervals were 
grouped as the initial visit, 1 to 14 days (2 weeks), 15 
to 45 days (1 month), 46 to 135 days (3 months), 
136 to 270 days (6 months), 271 to 547 days (I 
year), 548 to 912 days (2 years), and greater than 
912 days (3 years). 
Because most variables were not normally distrib- 
uted, all results are reported as the median and inter- 
quartile range (IQR, 25th to 75th percentile). In 
evaluating thrombotic risk factors and PE, patients 
with unilateral or bilateral isolated CVT were com- 
pared with those who had a proximal DVT with or 
without CVT in the contralatera] limb. Analysis of 
postthrombotic manifestations was performed on the 
basis of involved extremities after excluding limbs 
that had a history of DVT, hyperpigmentation, r 
ulceration. All extremities with CVT and at least one 
follow-up visit were included in the evaluation of 
propagation, recanalization, and the development of
valvular incompetence. Comparisons among cate- 
gorical variables were made using Pearson's X 2 or 
Fisher's exact est, whereas continuous variables were 
compared using the Mann-Whitney U test. In com- 
paring the prevalence of symptoms among unin- 
volved limbs contralateral to a CVT, extremities with 
CVT, and limbs with proximal DVT, the test for 
departure from a linear trend of proportions assumed 
equal increases across the three groups, t5 Statistical 
significance for all comparisons was defined as a p 
value of 0.05 or less. 
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RESULTS 
Presenting features of CVT. Over the 116- 
month interval from December 1986 to July 1996, 
499 patients with acute DVTs in 576 extremities 
were referred as candidates for the natural history 
study and have information regarding risk factors and 
presenting symptoms available. Among these, 58 pa- 
tients (12%) had an acute DVT confined to one or 
more calf veins in 62 extremities (11%). These 62 
extremities included 11 limbs (18%) with a proximal 
DVT in the contralateral extremity and eight limbs 
(13%) with a previous history of DVT or evidence of 
chronic venous disease (hyperpigmentation or ulcer- 
ation) in that limb. 
Among the 47 patients who had CVT and no 
contralateral proximal disease, thrombosis was uni- 
lateral on the right side in 21 (45%) patients, unilat- 
eral on the left side in 22 (47%), and bilateral in four 
(8%). Thrombosis in these 51 extremities involved 
the posterior tibial veins in 32 (63%) limbs, the per- 
oneal veins in 17 (33%), and the sural veins in six 
(12%). Twenty-seven patients (57%) were men, and 
the median age was 48 years (IQR, 36 to 67 years). 
The gender and age distribution were not statistically 
different from the 452 patients who had a proximal 
thrombosis (54% men; median age, 55 years; IQR~ 
39 to 68 years). Bilateral DVT was more common 
among patients with proximal thrombosis (16% vs 
9%), but this difference was not statistically signifi- 
cant (p = 0.17). The prevalence of thrombotic risk 
factors is shown in Table I. Concurrent malignancy 
was significantly ess common among CVT patients 
(p = 0.03), whereas the prevalence of other risk 
factors was not significantly different between the 
two groups. Patients with isolated CVT had a me- 
dian of one risk factor (IQR, 0 to 2) in comparison 
with two risk factors (IQR, i to 2) among those who 
had proximal thrombosis (p = 0.04; Fig. 1). 
A detailed assessment of pulmonary symptoms 
was not available for all patients. However, in those 
with such data, PE was diagnosed at presentation i  
five of 47 patients with CVT (11%) in comparison 
with 64 of 419 patients with proximal DVT (15%; 
p -- 0.46). Among patients with CVT, this diagnosis 
was suspected clinically in one patient and was estab- 
"lished by a high-probability ventilation/perfusion 
(V/Q) lung scan in four patients. 
Early clinical outcome. Among the 499 poten- 
tial candidates for inclusion in the natural history 
study, 268 were enrolled and had at least one fol- 
low-up visit. This included 29 patients with an iso- 
lated CVT (two bilateral) and 239 patients with a 
proximal DVT (six with contralateral CVT). The 
Table I. Risk factors 
Percent with risk factor* 
Risk factor Proximal DVT CVT p 
Malignancy 35,3% (416) 19.1% (47) 0,03 
Bedrest 35.2% (418) 23.4% (47) 0.11 
Recent surgery 32% (416) 36.2% (47) 0,56 
Previous venous disease 27.2% (452) 17% (47) 0.13 
Recent rauma 13.5% (378) 13.3% (45) 0,98 
Remote trauma 13.3% (375) 8.9% (45) 0,40 
Family history 9.1% (407) 6.4% (47) 0.79 
Recent ravel 4.8% (415) 2.1% (47) 0.71 
Congestive heart failure 4.1% (411) 2.1% (47) 1.0 
Pregnancy 1.9% (417) 2.1% (47) 1.0 
Oral contraceptives 1% (417) 0% (47) 1.0 
*Total number of patients assessed for individual risk factor. 
median follow-up was 163 days (IQR, 25 to 407 
days) for patients with isolated CVT versus 240 days 
(IQR, 28 to 1066 days) among those with a proxi- 
mal DVT (p = 0.26). Initial treatment with antico- 
agulants, thrombolytic agents, or a vena caval filter 
was undertaken i  229 patients with a proximal DVT 
(96%), in comparison with 21 patients with CVT 
(72%; p < 0.001; Table II)o Among patients with 
isolated CVT, one patient (3%) had a PE docfl- 
mented by V /Q scan 33 days after presentation. This 
patient was receiving anticoagulation medication at 
the time of the PE and had no evidence of proximal 
propagation by duplex ultrasonography. In contrast, 
14 of 239 patients (6%) with proximal DVT had a 
new diagnosis of PE during the course of follow-up. 
In evaluating postthrombotic manifestations, 50
extremities with CVT were available for analysis after 
excluding patients who had evidence of previous 
venous disease within either extremity. At the time of 
presentation, symptoms including edema (n = 21) 
and pain (n = 30) were present in 35 of these 50 
extremities (70%). Among patients enrolled in fol- 
low-up, the prevalence of symptoms progressively 
decreased over time such that nine of 27 limbs (33%) 
were symptomatic at2 weeks and three of 13 (23%) 
at 1 year. In contrast, only three of 35 uninvolved 
extremities (9%) contralateral to a CVT were symp- 
tomatic at presentation, with persistent symptoms in
9% of those followed-up for 1 year. Among limbs 
that had a proximal thrombosis, symptoms were 
present in 290 of 368 (79%) at presentation, decreas- 
ing to 51 of 95 (54%) after i year of follow-up (Fig. 
2). The prevalence of symptoms in limbs with CVT, 
normal limbs contralateral toa CVT, and extremities 
with proximal thrombosis was significantly different 
at 1 year (p = 0.004). These data are consistent with 
a linear trend in rates of symptoms across the three 
JOURNAL OF VASCULAR SURGERY 
752 Meissner et al. November 1997 
40% - [ 
35%- 
80% 
M.  
._w 25% er 
20O/o 
e-  
0 
g 15o/0 
M.  
0 
10o/° 
rr 
50/0 -
O% 
- - / / / /  
z / / /  
- - / / / j  
, / / /  
, / / /  
/ / / ,  
, / z¢  
5//A 
- - z / /~  
#Z 
0 1 2 3 4 
NUMBER OF RISK FACTORS 
] Isolated CVT 
Proximal DVT 
_.•i_........._..._iiilii• 
5 6 
Fig. 1. Number of thrombotic risk factors among patients with isolated CVT in comparison 
with patients with a proximal DVT. Median number of risk factors was significantly greater (p = 
0.04) among patients with a proximal DVT. 
Table II. Initial DVT treatment 
Proximal D VT (%) CVT (%) 
Treatment (n = 239) (n ~- 29) 
Andcoagutation 212 (88.7) 21 (72.4) 
Vena caval filter 28 (11.7) 2 (6.9) 
Thrombolytic therapy 2 (0.8) 0 (0) 
Unknown 1 (0.4) 2 (6.9) 
No treatment 9 (3.8) 6 (20.7) 
groups: uninvolved contralateral limbs (9%), isolated 
calf thrombosis limbs (23%), and proximal DVT 
limbs (54%; p > 0.5 for rejecting hypothesis of linear 
trend). The number of extremities with isolated CVT 
followed-up beyond 1 year was too small for mean- 
ingful comparison. Persistent symptoms in CVT 
limbs were limited to pain and swelling, with no 
hyperpigmentation r ulceration developing during 
follow-up. Although no ulceration was observed 
among patients with proximal DVT at 1 year, hyper- 
pigmentation had developed in three patients (3%). 
Early venous outcome. Recanalization, propa- 
gation, and the development of valvular incompe- 
tence were evaluated in the 37 limbs with CVT and 
at least one follow-up visit. The median follow-up 
among these extremities was 111 days (IQR, 26 to 
391 days). Recanalization proceeded rapidly from an 
initial median tibial thrombosis core of 4 such that 
the median score was reduced by 50% at 1 month 
and to 0 at 1 year (Fig. 3). Propagation to a more 
proximal evel in the same extremity occurred in six 
limbs (16%), four (13%) of those with isolated CVT 
in comparison with two extremities (29%) with GVT 
contralateral to a proximal thrombosis (p = 0.32). 
Among these six extremities, two had propagation 
limited to the popliteal vein; two to the popliteal and 
superficial femoral vein; one to the common femoral 
and profunda veins; and one to the external i iac vein. 
Propagation occurred a median of 29 days (range, 4 
to 34 days) after presentation, at which time one 
patient was being anticoagulated with heparin and 
two with warfarin. 
In analyzing the development of reflux in these 
37 extremities, each involved vein was considered 
separately and presumed to behave independently of
thrombus in other calf veins. A total of 52 initially 
thrombosed, individual calf veins were therefore 
available for analysis. Reflux was not observed in any 
involved vein until the twelfth week, after which the 
prevalence of reflux progressively increased to 24% at 
1 year (Fig. 4). In contrast, among 104 uninvolved 
peroneal and posterior tibial vein segments in 26 
contralateral limbs, reflux was present in one seg- 
ment at the time of  presentation and was not noted 
to develop in any other segments during follow-up. 
The prevalence of reflux among involved (five of 21) 
and contralateral uninvolved (0 of 48) calf vein seg- 
ments was significantly different (p = 0.002) at 1 year. 
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Fig. 2. Prevalence of symptoms (edema, pain, hyperpigmentation, r ulceration) during 
follow-up among extremities with proximal DVT, CVT, and in uninvolved limbs contralateral 
to a CVT. Differences among the three groups are statistically significant at 12 months (p = 
0.004). Table shows total number of extremities within each group evaluated at each follow-up 
interval. 
DISCUSSION 
The most important issues in defining the clinical 
relevance, and thus appropriate treatment, of acute 
DVT are the rates of PE and development of the 
postthrombotic syndrome. Recurrent thrombotic 
events are associated with an increased risk of both 
PE and valvular incompetence 2a6 and are also an 
important consideration. Although our understand- 
ing remains incomplete, the relationship between 
proximal DVT, PE, and recurrent hrombosis has 
been extensively investigated and optimal treatment 
established. Early therapeutic anticoagulation with 
hepatin followed by oral warfarin is critical in pre- 
venting recurrent venous thromboembolism in this 
setting? ,4The natural history of proximal DVT with 
respect to the postthrombotic syndrome has also 
been well described. Manifestations of pain, hyper- 
"pigmentation, and ulceration develop during long- 
term follow-up in 29% to 79% of patients. 1,2,17 Be- 
cause rates of recanalization, recurrent hrombotic 
events, and persistent proximal obstruction are major 
determinants of postthrombotic sequelae, 2,16,18 
long-term outcome may also be influenced by early 
treatment and should be considered in defining ther- 
apy. 
In contrast, the natural history of CVT remains 
poorly defined and controversial. At least some of the 
confusion may arise from the fact that thrombi de- 
tected in screening asymptomatic high-risk patients 
may behave differently than symptomatic thrombi. 
Asymptomatic thrombi are often smaller, more often 
confined to the tibial veins, and more frequently 
nonocclusive than symptomatic thrombi. 6a9 Detec- 
tion of these small thrombi by duplex ultrasonogra- 
phy is also more difficult. 13 The natural history of 
these thrombi may differ from symptomatic CVT, 
which is substantially ess common than proximal 
venous thrombosis among symptomatic pa- 
tients.20, 2~ 
Furthermore, discussions regarding the clinical 
significance of CVT have often been limited to the 
risk of PE, the investigation of which has yielded 
conflicting results. It does appear that the incidence 
of clinically significant PE with isolated CVT is less 
than with proximal DVT and that most emboli that 
occur in this setting are small. 8 However, whether 
this rate is trivial remains in dispute. For example, the 
incidence of symptomatic PE among patients with 
asymptomatic CVT discovered in routine screening 
of postoperative patients has been reported to be as 
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Fig. 3. Median thrombosis score versus follow-up interval among extremities with CVT. Error 
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Fig. 4. Prevalence of reflux with respect to follow-up interval among veins with isolated tibial 
thrombosis. Numbers represent the number of calf vein segments (posterior t bial, peroneal, 
sural) evaluated at each follow-up interval. 
low as 0% to 2%. 9,11 Such observations support he 
conclusion of  Philbrick and Becker 7 that, based on 
reports, in the literature, PE rarely occurs in the 
absence of proximal propagation. In contrast, Lohr 
et al. 22 observed pulmonary emboli at presentation i  
5% of patients and concluded that CVT was not a 
benign disorder. Similarly, studies that used routine 
lung scanning have documented pulmonary emboli 
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in 33% of patients with CVT, 44% of which were 
estimated to involve greater than 20% of the lung 
volume, s 
The relationship between CVT and development 
of the postthrombotic syndrome is even less clear. 
Based on a 20% rate of proximal propagation, Hirsh 
and Lensing 6 calculated that postthrombotic mani- 
festations would develop 4% of patients with CVT, 
whereas Philbrick and Becker 7 concluded that the 
evidence is too limited to show a relationship be- 
tween CVT and chronic venous disease. A lower 
incidence of postthrombotic sequelae might be ex- 
pected with CVT because these thrombi tend to 
recanalize more rapidly than proximal thromboses 18
and are not associated with persistent proximal ob- 
struction. However, recurrent thrombotic events, re- 
ported in approximately 20% of untreated CVT pa- 
tients, 12,23 may also contribute to the development 
of valvular incompetence. 16 Despite initial anticoag- 
ulation in 72% of patients in this study, the 16% 
incidence of proximal propagation is remarkably sim- 
ilar to that reported in untreated patients. Although 
these rates are lower than the 30% incidence report- 
ed 16 among patients with proximal DVT, likely re- 
flecting the fewer number of risk factors and lower 
prevalence of malignancy in CVT patients, they may 
be a cause for concern. These concerns tend to be 
validated by studies that report late symptoms (4 to 7 
years) in 22% to 47% of patients after CVT. 17,2~ A
similar prevalence of abnormal clinical or hemody- 
namic findings has been reported in uninvolved 
limbs, although few of these extremities have been 
noninvasively followed-up to exclude recurrent 
thrombotic events. 
Although this study only provides information 
regarding the early outcome after isolated CVT, it 
does suggest hat the long-term prognosis is not 
entirely benign. As previously suggested, 2s tibial vein 
recanalization begins early after the acute event and 
is essentially complete in the majority of patients by 1 
year. Similarly, the prevalence of symptoms rapidly 
decreases within 2 weeks of presentation. However, 
approximately one quarter of involved limbs will re- 
main symptomatic after 1 year. The proportion of 
symptomatic limbs is less than after a proximal DVT, 
but is substantially higher than in the contralateral 
tminvolved extremity. This is in distinct contrast o 
reports that 93% of initially symptomatic patients are 
asymptomatic within 3 months 23 and is consistent 
with the prevalence of late symptoms reported by 
others. 17,24,26 The finding that symptoms were lim- 
ited to edema and pain is not surprising given the 
short follow-up interval. Whether these patients 
would progress to the development ofhyperpigmen- 
ration and ulceration is unknown, but the 24% prev- 
alence of reflux at i year may make such late manifes- 
tations possible. Reports of late ambulatory venous 
pressure levations among patients followed-up after 
isolated CVT suggest hat such reflux does have 
hemodynamic significance. 17,24,27 
In addition, although this study was designed to 
follow the natural history of DVT with respect o 
chronic lower extremity manifestations, it confirms 
reports that PE may be associated with calf vein 
thromboses. Six patients either originally had or de- 
veloped symptomatic PE during follow-up, with this 
diagnosis confirmed by V /Q lung scanning in five 
patients. Although embolization of a proximal exten- 
sion before presentation cannot be excluded, this 
finding validates earlier suggestions that pulmonary 
symptoms in the patient with CVT warrant horough 
evaluation. 2s
With respect o the clinical management of pa- 
tients with isolated tibial thrombosis, this study does 
not specifically address the need for anticoagulation. 
However, among 35 patients followed-up for CVT 
in one extremity, six had a contralateral proximal 
DVT, four patients had a previous history of venous 
disease, four patients had a PE, one had a PE during 
follow-up, and four had proximal propagation. Thus 
19 of 35 patients (54%) followed-up for a CVT in 
one extremity had established indications for antico- 
agulation therapy either at presentation or during 
follow-up. The impact ofanticoagulation medication 
in minimizing development of the postthrombotic 
syndrome isunknown but certainly has the potential 
to decrease the impact ofthrombus propagation and 
recurrent hrombosis as contributing factors. Fur- 
thermore, this study does suggest that isolated CVT 
should not be regarded as a clinically insignificant 
event. Although less than after a proximal DVT, the 
number of patients that remain symptomatic and the 
incidence of valvular incompetence after 1 year of 
follow-up is not trivial. Whether this will be associ- 
ated with the development of lipodermatosclerosis 
and ulceration isnot known, but it at least argues for 
consideration of late lower extremity symptoms in 
evaluating the importance and treatment of CVT. 
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